Costa Rica Analgesic Industry Outlook 2022 - 2026

See how Costa Rica Analgesic performed compared to key markets such as Germany, Spain and Canada.

Key Market Indicators

Sales of analgesic medicines in Costa Rica are estimated to hit $10.88 million by 2026. This is up from $9.02 million in 2021, representing an average annual growth of 3.6%. Since 2012, the Costa Rican market has grown by 13.5% per year. In 2021, it ranked 25th globally, with Iceland leading the way at $9.02 million. Spain, Canada, and Italy were the next three largest markets, respectively.

Marketing Banner

Costa Rica Analgesic Market Data and Forecasts

How much will Costa Rica Analgesic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Costa Rica
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Costa Rica
Forecast: Analgesic Medicine Sales in Costa Rica
Forecast: Analgesic Medicine Sales in Costa Rica
Forecast: Analgesic Medicine Sales in Costa Rica
More in Analgesic Industry for 2028